1. Limitations of the ACS NSQIP in Thyroid Surgery

   • Rebecca S. Sippel
   • Herbert Chen

   Endocrine Tumors 14 July 2011 Pages: 3529 - 3530

2. Melanoma in the Older Patient: Measuring Frailty as an Index of Survival

   • Julie R. Lange
   • Sewon Kang
   • Charles M. Balch

   Melanomas 31 August 2011 Pages: 3531 - 3532

3. Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer: The Future Ain’t What It Used To Be

   • Peter J. Allen

   Pancreatic Tumors 27 September 2011 Pages: 3533 - 3534

4. Quality Improvement in Multidisciplinary Cancer Teams: An Investigation of Teamwork and Clinical Decision-Making and Cross-Validation of Assessments

   • B. W. Lamb
   • N. Sevdalis
   • J. S. A. Green

   Healthcare Policy and Outcomes 19 May 2011 Pages: 3535 - 3543

   

5. Features Associated with Successful Recruitment of Diverse Patients onto Cancer Clinical Trials: Report from the American College of Surgeons Oncology Group

   • Kathleen M. Diehl
   • Erin M. Green
   • Lisa A. Newman

   Healthcare Policy and Outcomes 17 June 2011 Pages: 3544 - 3550

6. Medical and Surgical Risks in Thyroid Surgery: Lessons from the NSQIP

   • Melanie Goldfarb
   • Zvi Perry
   • Sareh Parangi

   Endocrine Tumors 20 July 2011 Pages: 3551 - 3558

   

7. Risk Factors for Nonsynchronous Second Primary Malignancy and Related Death in Patients with Differentiated Thyroid Carcinoma

   • Brian Hung-Hin Lang
   • Kai Pun Wong

   Endocrine Tumors Open access 15 May 2011 Pages: 3559 - 3565

8. Both BRAF V600E Mutation and Older Age (≥65 Years) are Associated with Recurrent Papillary Thyroid Cancer

   • Gina M. Howell
   • Sally E. Carty
   • Linwah Yip

   Endocrine Tumors 19 May 2011 Pages: 3566 - 3571

9. Staging of Papillary Thyroid Carcinoma with Ultrasonography: Performance in a Large Series

   • Ji Soo Choi
   • Woong Youn Chung
   • Eun-Kyung Kim

   Endocrine Tumors 19 May 2011 Pages: 3572 - 3578

10. Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma

    • Michael S. Sabel
    • Jay Lee
    • Stewart Wang

    Melanomas 06 August 2011 Pages: 3579 - 3585

    

11. Outcome After Therapeutic Lymph Node Dissection in Patients with Unknown Primary Melanoma Site

    • Sebastiaan P. Prens
    • Augustinus P. T. van der Ploeg
    • Cornelis Verhoef

    Melanomas Open access 25 May 2011 Pages: 3586 - 3592

    

12. Factors Predictive of the Status of Sentinel Lymph Nodes in Melanoma Patients from a Large Multicenter Database

    • Richard L. White Jr.
    • Gregory D. Ayers
    • for the Sentinel Lymph Node Working Group

    Melanomas 07 June 2011 Pages: 3593 - 3600

    

13. Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer

    • Yun Shin Chun
    • Harry S. Cooper
    • John P. Hoffman

    Pancreatic Tumors 27 September 2011 Pages: 3601 - 3607

    

14. Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail: A Novel Prognostic Parameter for Patient Selection

    • Stefano Partelli
    • Stefano Crippa
    • Massimo Falconi

    Pancreatic Tumors 17 May 2011 Pages: 3608 - 3614

    

15. Survival and Quality of Life of Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Interferon-Based Chemoradiation: A Phase II Trial

    • Matthew H. G. Katz
    • Robert Wolff
    • Peter W. T. Pisters

    Pancreatic Tumors 24 June 2011 Pages: 3615 - 3622

    

16. Robot-Assisted Spleen-Preserving Laparoscopic Distal Pancreatectomy

    • Sung Hoon Choi
    • Chang Moo Kang
    • Hoon Sang Chi

    Original Article - Pancreatic Tumors 12 June 2011 Pages: 3623 - 3623

17. Adjuvant Chemolipiodolization Reduces Early Recurrence Derived from Intrahepatic Metastasis of Hepatocellular Carcinoma After Hepatectomy

    • Masaki Ueno
    • Kazuhisa Uchiyama
    • Hiroki Yamaue

    Hepatobiliary Tumors 26 May 2011 Pages: 3624 - 3631

    

18. Locoregional Therapy-Induced Tumor Necrosis as a Predictor of Recurrence after Liver Transplant in Patients with Hepatocellular Carcinoma

    • Meng-Hsing Ho
    • Chih-Yung Yu
    • Chung-Bao Hsieh

    Hepatobiliary Tumors 28 May 2011 Pages: 3632 - 3639

    

19. The Predictive Value of Postoperative Clinical Risk Scores for Outcome After Hepatic Resection: A Validation Analysis in 807 Patients

    • Nuh N. Rahbari
    • Christoph Reissfelder
    • Jürgen Weitz

    Hepatobiliary Tumors 15 June 2011 Pages: 3640 - 3649

    

20. Efficacy of Surgical Microwave Therapy in Patients with Unresectable Hepatocellular Carcinoma

    • Shinji Itoh
    • Yasuharu Ikeda
    • Kenji Takenaka

    Hepatobiliary Tumors 15 June 2011 Pages: 3650 - 3656

    

21. Surgery Versus Intra-arterial Therapy for Neuroendocrine Liver Metastasis: A Multicenter International Analysis

    • Skye C. Mayo
    • Mechteld C. de Jong
    • Timothy M. Pawlik

    Hepatobiliary Tumors 17 June 2011 Pages: 3657 - 3665

    

22. Recurrence Rates and Prognostic Factors in ypN0 Rectal Cancer After Neoadjuvant Chemoradiation and Total Mesorectal Excision

    • Anand Govindarajan
    • Diane Reidy
    • Garrett M. Nash

    Colorectal Cancer 18 May 2011 Pages: 3666 - 3672

    

23. Survival and Quality of Life Following Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colonic Origin

    • Adrienne R. Hill
    • Richard P. McQuellon
    • Edward A. Levine

    Colorectal Cancer 15 June 2011 Pages: 3673 - 3679

    

24. The Revised ACPGBI Model is a Simple and Accurate Predictor of Operative Mortality After Potentially Curative Resection of Colorectal Cancer

    • Colin H. Richards
    • E. Fiona Leitch
    • Paul G. Horgan

    Colorectal Cancer 15 June 2011 Pages: 3680 - 3685

25. Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies

    • Claudio Belluco
    • Antonino De Paoli
    • Francesco De Marchi

    Colorectal Cancer Open access 21 June 2011 Pages: 3686 - 3693

    

26. Molecular Profiling of Colon Tumors: The Search for Clinically Relevant Biomarkers of Progression, Prognosis, Therapeutics, and Predisposition

    • Manny D. Bacolod
    • Francis Barany

    Colorectal Cancer 24 February 2011 Pages: 3694 - 3700

    

27. Laparoscopy-Assisted Distal Gastrectomy for Early Gastric Cancer: A Video Demonstration

    • Seigo Kitano
    • Tsuyoshi Etoh
    • Norio Shiraishi

    Gastrointestinal Oncology 02 July 2011 Pages: 3701 - 3701

28. Viable Tumor Tissue Adherent to Needle Applicators after Local Ablation: A Risk Factor for Local Tumor Progression

    • Nikol Snoeren
    • Joost Huiskens
    • Thomas M. van Gulik

    Gastrointestinal Oncology Open access 18 May 2011 Pages: 3702 - 3710

    

29. Oral Vitamin B12 Replacement: An Effective Treatment for Vitamin B12 Deficiency After Total Gastrectomy in Gastric Cancer Patients

    • Hyoung-Il Kim
    • Woo Jin Hyung
    • Sung Hoon Noh

    Gastrointestinal Oncology 10 May 2011 Pages: 3711 - 3717

    

30. Borrmann’s Macroscopic Criteria and p-Smad2 Expression Are Useful Predictive Prognostic Markers for Cytology-Positive Gastric Cancer Patients Without Overt Peritoneal Metastasis

    • Satoru Noda
    • Masakazu Yashiro
    • Kosei Hirakawa

    Gastrointestinal Oncology 15 May 2011 Pages: 3718 - 3725

    

31. Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients with Peritoneal Dissemination

    • Yoshiyuki Fujiwara
    • Shuji Takiguchi
    • Yuichiro Doki

    Gastrointestinal Oncology 17 May 2011 Pages: 3726 - 3731

    

32. Safety of Thoracoscopic Lobectomy in Locally Advanced Lung Cancer

    • Mark Hennon
    • Rohit K. Sahai
    • Chukwumere Nwogu

    Thoracic Oncology 12 July 2011 Pages: 3732 - 3736

    

33. Modified Pleural Tenting for Prevention of Anastomotic Leak After Ivor Lewis Esophagogastrectomy

    • Christos Asteriou
    • Nikolaos Barbetakis
    • Christodoulos Tsilikas

    Thoracic Oncology 15 June 2011 Pages: 3737 - 3742

    

34. Nodal Metastasis From Locally Advanced Esophageal Cancer: How Neoadjuvant Therapy Modifies Their Frequency and Distribution

    • Carlo Castoro
    • Marco Scarpa
    • Ermanno Ancona

    Gastrointestinal Oncology 10 May 2011 Pages: 3743 - 3754

    

35. Oncologic Impact of the Curettage of Grade 2 Central Chondrosarcoma of the Extremity

    • Wan Hyeong Cho
    • Won Seok Song
    • Soo-Yong Lee

    Bone and Soft Tissue Sarcomas 25 May 2011 Pages: 3755 - 3761

    

36. Diagnosis, Management, and Outcome of Patients with Dedifferentiated Liposarcoma Systemic Metastasis

    • Markus P. Ghadimi
    • Tariq Al-Zaid
    • Dina Lev

    Bone and Soft Tissue Sarcomas 26 May 2011 Pages: 3762 - 3770

    

37. Sarcoma Lung Metastases Treated with Percutaneous Radiofrequency Ablation: Results from 29 Patients

    • J. Palussière
    • A. Italiano
    • B. N. Bui

    Bone and Soft Tissue Sarcomas 03 June 2011 Pages: 3771 - 3777

    

38. Outcomes of Screening-Detected Ductal Carcinoma In Situ Treated with Wide Excision Alone

    • Jonathan Fong
    • Emil D. Kurniawan
    • G. Bruce Mann

    Breast Oncology 01 June 2011 Pages: 3778 - 3784

    

39. Office Ductoscopy for Surgical Selection in Women with Pathologic Nipple Discharge

    • Seema A. Khan
    • Amrit Mangat
    • Nora Hansen

    Breast Oncology 28 May 2011 Pages: 3785 - 3790

    

40. Sentinel Lymph Node Pressure in Breast Cancer

    • S. David Nathanson
    • Meredith Mahan

    Breast Oncology 28 May 2011 Pages: 3791 - 3796

    

41. The Safety of Multiple Re-excisions after Lumpectomy for Breast Cancer

    • Suzanne Coopey
    • Barbara L. Smith
    • Michelle C. Specht

    Breast Oncology 01 June 2011 Pages: 3797 - 3801

    

42. Needle Versus Excisional Biopsy for Noninvasive and Invasive Breast Cancer: Report from the National Cancer Data Base, 2003–2008

    • Richelle T. Williams
    • Katharine Yao
    • David P. Winchester

    Breast Oncology 01 June 2011 Pages: 3802 - 3810

    

43. Prognostic Value of Pathological Resection Margin Distance in Squamous Cell Cancer of the Vulva

    • Linn Woelber
    • Matthias Choschzick
    • Sven Mahner

    Gynecologic Oncology 19 May 2011 Pages: 3811 - 3818

    

44. Risk and Predictors of Malignancy in Women with Endometrial Polyps

    • Stephanie L. Wethington
    • Thomas J. Herzog
    • Jason D. Wright

    Gynecologic Oncology 24 June 2011 Pages: 3819 - 3823

45. Is Neo-adjuvant Chemotherapy a “Waiver” of Extensive Upper Abdominal Surgery in Advanced Epithelial Ovarian Cancer?

    • Sokbom Kang
    • Yoo Heon Jong
    • Sang-Yoon Park

    Gynecologic Oncology 21 June 2011 Pages: 3824 - 3827

46. Significance of Perineural Invasion, Lymphovascular Invasion, and High-Grade Prostatic Intraepithelial Neoplasia in Robot-Assisted Laparoscopic Radical Prostatectomy

    • Jae Hung Jung
    • Jae Won Lee
    • Koon Ho Rha

    Urologic Oncology 10 June 2011 Pages: 3828 - 3832

    

47. Oncologic Outcomes and Survival in pT0 Tumors After Radical Cystectomy in Patients Without Neoadjuvant Chemotherapy: Results from a Large Multicentre Collaborative Study

    • Morgan Rouprêt
    • Sarah J. Drouin
    • for the Bladder Cancer Committee of the French National Association of Urology (“CC-AFU Vessie”)

    Urologic Oncology 07 June 2011 Pages: 3833 - 3838

    

48. Basal-Like Breast Cancer Defined by FOXC1 Expression Offers Superior Prognostic Value: A Retrospective Immunohistochemical Study

    • Partha S. Ray
    • Sanjay P. Bagaria
    • Armando E. Giuliano

    Translational Research and Biomarkers 18 March 2011 Pages: 3839 - 3847

    

49. Suppression of T-Cell Expansion by Melanoma is Exerted on Resting Cells

    • Andrew J. Russ
    • Lucy Wentworth
    • Clifford S. Cho

    Translational Research and Biomarkers 05 April 2011 Pages: 3848 - 3857

    

50. Decreased Expression of RASSF6 Is a Novel Independent Prognostic Marker of a Worse Outcome in Gastric Cancer Patients after Curative Surgery

    • Yugang Wen
    • Quan Wang
    • Zhihai Peng

    Translational Research and Biomarkers 26 March 2011 Pages: 3858 - 3867